Phenobarbital
CAS Number
50-06-6Synonym
Adonal; Amylofene; Barbenyl; Barbonal; Barbophen; Bartol; Cabronal; Calminal; Codibarbita; Dezibarbitur; Duneryl; Ensodorm; Epidorm; Episedal; Eskabarb; 5-ethyl-5-phenylbarbituric acid; Etilfen; Fenbital; Fenobarbital; Gardepanyl; Glysoletten; Haplos; Hennoletten; Hypnogen; Lefebar; Lepinal; Linasen; Lubergal; Lumen; Lumesettes; Luramin; Neurobarb; Noptil; Parkotal; Phenaemal; Phenemalum; Phenobarb; Phenobarbituric acid; Phenoluric; Phenomet; Phenylethylbarbiturate; Phenylethylbarbituric acid; 5-phenyl-5-ethylbarbituric acid; Phenylethylmalonylurea; Phenyletten; Phenyral; Phob; Polcominal; Promptonal; Seda-tabilen; Sedicat; Sedizorin; Sedofen; Sedonal; Sedophen; Sombutol; Somnosan; Somonal; Starifen; Thenobarbital; Theominal; Tridezibarbitur; Versomnal; Zadonal
Occurrence/Use
Medicine (sedative), laboratory reagent. Also available as the sodium salt which has good water-solubility
| Latest Criteria: |
Proposition 65 NSRLs/MADLs
|
|---|---|
| Inhalation Unit Risk (μg/cubic meter)-1: |
1.3 E-4
|
| Inhalation Slope Factor (mg/kg-day)-1: |
4.6 E-1
|
| Oral Slope Factor (mg/kg-day)-1: |
4.6 E-1
|
| Comments/References: |
Proposition 65
| Cancer: |
Currently listed
|
|---|
| Listed as causing: |
Cancer
|
|---|---|
| Date of Listing: |
01/01/1990
|
| Basis for Listing: |
Authoritative Bodies-International Agency for Research on Cancer
|
| Cancer | |
| No Significant Risk Level (NSRL): |
2 µg/day
|
|---|---|
| Last NSRL/MADL Revision: |
1992
|
| Cancer: |
|---|
